Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has entered into an agreement with Zaza Industrial Holdings K.K, Japan, under which Sun Pharma has agreed to sell 100% shares held in Sun Pharma Japan Technical Operations, a step-down subsidiary of the Company (through its subsidiary, Sun Pharma Japan). Consequently, Sun Pharma Japan Technical Operations shall cease to be a subsidiary of the Company. The said transaction is expected to be completed by January 31, 2025. 

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.